Ellen M. Westerhout

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.

Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.

Journal: Scientific reports

Published: May 31, 2025

Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.

Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.

Journal: Cancer research

Published: July 18, 2022

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.

Journal: JCI insight

Published: August 03, 2021

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.

Journal: Cancer research

Published: May 22, 2021

FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.

FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.

Journal: Aging cell

Published: October 11, 2019

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.

Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.

Journal: EBioMedicine

Published: October 04, 2018

A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.

A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.

Journal: Nature communications

Published: July 19, 2018

ALK positively regulates MYCN activity through repression of HBP1 expression.

ALK positively regulates MYCN activity through repression of HBP1 expression.

Journal: Oncogene

Published: October 16, 2017

Neuroblastoma is composed of two super-enhancer-associated differentiation states.

Neuroblastoma is composed of two super-enhancer-associated differentiation states.

Journal: Nature genetics

Published: December 19, 2016

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.

Journal: Oncotarget

Published: November 26, 2015

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.

Journal: Nature genetics

Published: January 15, 2015

Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenate.

Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenate.

Journal: Journal of pharmaceutical and biomedical analysis

Published: November 11, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026